Injectable Drug
- All
- News
- Videos
-
Breast Cancer Drug Delivery Gets Precise Through Nano Injection Platform Developed By IIT Madras
- Monday December 22, 2025
- Health | Indo-Asian News Service
An international team of researchers led by the Indian Institute of Technology (IIT) Madras has developed a cutting-edge nanoinjection drug delivery platform that has the potential to make breast cancer treatment safer.
-
www.ndtv.com
-
Ozempic Enters India: Diabetes Drug, Not A Miracle Fix, Novo Nordisk MD To NDTV
- Sunday December 14, 2025
- Health | Written by Tanushka Dutta
In an exclusive interaction with NDTV, Managing Director of Novo Nordisk India, Vikrant Shrotriya, said the launch of injectable semaglutide marks a significant moment for diabetes treatment.
-
www.ndtv.com
-
Ozempic Too Costly? 7 Cheaper And Clinically Approved Alternatives Available In India
- Friday December 12, 2025
- Health | Written by Rupashi Chhabra
Ozempic has hit the Indian market and will be available at Rs 2,200 per week. But did you know that there are alternatives which can also aid in weight loss?
-
www.ndtv.com
-
Can Non-Diabetics Take Ozempic For Weight Loss? Doctor Answers
- Friday December 12, 2025
- Health | Written by Varsha Vats
Ozempic is the brand name for a medication called semaglutide, which is primarily used to manage type 2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists
-
www.ndtv.com
-
Ozempic Injection Price In India: How Affordable Is It For Diabetes And Weight Loss?
- Friday December 12, 2025
- Health | Written by Shreya Goswami
Ozempic, a once-weekly semaglutide injection for type-2 diabetes, has debuted in India with pricing starting at roughly Rs 2,200 per week.
-
www.ndtv.com
-
Ozempic Launched In India: Doctors Welcome New Diabetes Drug, Warn Against Misuse For Weight Loss
- Friday December 12, 2025
- Health | Written by Debosmita Ghosh
Doctors highlight that the drug should be administered along with a healthy diet and regular exercise for management of type 2 diabetes, and not just as cosmetic procedure for weight loss.
-
www.ndtv.com
-
Diabetes, Weight Loss Drug Ozempic Launched In India: See Dosage, Price And More
- Friday December 12, 2025
- Health | Indo-Asian News Service
Novo Nordisk on Friday launched its blockbuster weight-loss drug Ozempic in India, beginning at Rs 8,800 a month or four weeks.
-
www.ndtv.com
-
2 Hyderabad Men Die After Injecting Stolen Surgical Anaesthesia Drug
- Thursday December 11, 2025
- India News | Reported by Uma Sudhir
Investigation revealed that the anaesthesia drug was stolen from a private hospital, highlighting a critical lapse in the handling of controlled substances.
-
www.ndtv.com
-
"Fresh Hope": Groundbreaking HIV Prevention Shots Begin In Africa
- Monday December 1, 2025
- World News | Agence France-Presse
South Africa, Eswatini and Zambia on Monday began administering a groundbreaking new HIV-prevention injection in the drug's first public rollouts in Africa, which has the world's highest HIV burden.
-
www.ndtv.com
-
World AMR Awareness Week 2025: Doctor Explains How Careful Prescribing Protects The Power Of Antibiotics
- Tuesday November 18, 2025
- Health | Written by Shreya Goswami
As antibiotic resistance rises globally, doctors warn that misuse and self-medication are weakening our most powerful drugs. For AMR Awareness Week 2025, an infectious-disease specialist explains how careful prescribing, stewardship and public awaren
-
www.ndtv.com
-
New Experimental Drug Enlicitide May Cut "Bad" Cholesterol By Up To 60%
- Tuesday November 11, 2025
- Health | Written by Shreya Goswami
A new daily oral medication, enlicitide, has shown reductions in LDL cholesterol of up to 60% in a late-stage Phase 3 trial, matching the efficacy of injectable PCSK9 inhibitors.
-
www.ndtv.com
-
Novo Nordisk Partners With Emcure To Launch Weight Loss Drug Poviztra In India
- Tuesday November 11, 2025
- Health | Press Trust of India
Emcure Pharma becomes the first Indian company to hold exclusive rights to distribute and commercialise Poviztra, a semaglutide injection 2.4 mg for weight loss, the statement said.
-
www.ndtv.com
-
Why 'Bluetoothing', A Shocking Blood-Sharing Trend To Get High, Has Health Experts Worried
- Thursday October 9, 2025
- Lifestyle | Written by NDTV Lifestyle Desk
Bluetoothing is a practice where one person injects themselves with a drug, then another person injects that first users blood into their own body
-
www.ndtv.com/lifestyle
-
Ozempic Launched In India: 14 Facts About The Diabetes, Weight Loss Drug
- Friday December 12, 2025
- Health | Written by Shreya Goswami
Semaglutide (Ozempic), a once-weekly injectable already approved globally, has now been launched in India for type 2 diabetes.
-
www.ndtv.com
-
Ozempic Cleared For Use In India: Pros, Cons And Prices
- Friday December 12, 2025
- Health | Reported by Tanushka Dutta
Ozempic is the trade name for semaglutide, a once-weekly injectable medicine that belongs to the class called GLP-1 receptor agonists. A higher-dose semaglutide better known as Wegovy is licensed for chronic weight management.
-
www.ndtv.com
-
Breast Cancer Drug Delivery Gets Precise Through Nano Injection Platform Developed By IIT Madras
- Monday December 22, 2025
- Health | Indo-Asian News Service
An international team of researchers led by the Indian Institute of Technology (IIT) Madras has developed a cutting-edge nanoinjection drug delivery platform that has the potential to make breast cancer treatment safer.
-
www.ndtv.com
-
Ozempic Enters India: Diabetes Drug, Not A Miracle Fix, Novo Nordisk MD To NDTV
- Sunday December 14, 2025
- Health | Written by Tanushka Dutta
In an exclusive interaction with NDTV, Managing Director of Novo Nordisk India, Vikrant Shrotriya, said the launch of injectable semaglutide marks a significant moment for diabetes treatment.
-
www.ndtv.com
-
Ozempic Too Costly? 7 Cheaper And Clinically Approved Alternatives Available In India
- Friday December 12, 2025
- Health | Written by Rupashi Chhabra
Ozempic has hit the Indian market and will be available at Rs 2,200 per week. But did you know that there are alternatives which can also aid in weight loss?
-
www.ndtv.com
-
Can Non-Diabetics Take Ozempic For Weight Loss? Doctor Answers
- Friday December 12, 2025
- Health | Written by Varsha Vats
Ozempic is the brand name for a medication called semaglutide, which is primarily used to manage type 2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists
-
www.ndtv.com
-
Ozempic Injection Price In India: How Affordable Is It For Diabetes And Weight Loss?
- Friday December 12, 2025
- Health | Written by Shreya Goswami
Ozempic, a once-weekly semaglutide injection for type-2 diabetes, has debuted in India with pricing starting at roughly Rs 2,200 per week.
-
www.ndtv.com
-
Ozempic Launched In India: Doctors Welcome New Diabetes Drug, Warn Against Misuse For Weight Loss
- Friday December 12, 2025
- Health | Written by Debosmita Ghosh
Doctors highlight that the drug should be administered along with a healthy diet and regular exercise for management of type 2 diabetes, and not just as cosmetic procedure for weight loss.
-
www.ndtv.com
-
Diabetes, Weight Loss Drug Ozempic Launched In India: See Dosage, Price And More
- Friday December 12, 2025
- Health | Indo-Asian News Service
Novo Nordisk on Friday launched its blockbuster weight-loss drug Ozempic in India, beginning at Rs 8,800 a month or four weeks.
-
www.ndtv.com
-
2 Hyderabad Men Die After Injecting Stolen Surgical Anaesthesia Drug
- Thursday December 11, 2025
- India News | Reported by Uma Sudhir
Investigation revealed that the anaesthesia drug was stolen from a private hospital, highlighting a critical lapse in the handling of controlled substances.
-
www.ndtv.com
-
"Fresh Hope": Groundbreaking HIV Prevention Shots Begin In Africa
- Monday December 1, 2025
- World News | Agence France-Presse
South Africa, Eswatini and Zambia on Monday began administering a groundbreaking new HIV-prevention injection in the drug's first public rollouts in Africa, which has the world's highest HIV burden.
-
www.ndtv.com
-
World AMR Awareness Week 2025: Doctor Explains How Careful Prescribing Protects The Power Of Antibiotics
- Tuesday November 18, 2025
- Health | Written by Shreya Goswami
As antibiotic resistance rises globally, doctors warn that misuse and self-medication are weakening our most powerful drugs. For AMR Awareness Week 2025, an infectious-disease specialist explains how careful prescribing, stewardship and public awaren
-
www.ndtv.com
-
New Experimental Drug Enlicitide May Cut "Bad" Cholesterol By Up To 60%
- Tuesday November 11, 2025
- Health | Written by Shreya Goswami
A new daily oral medication, enlicitide, has shown reductions in LDL cholesterol of up to 60% in a late-stage Phase 3 trial, matching the efficacy of injectable PCSK9 inhibitors.
-
www.ndtv.com
-
Novo Nordisk Partners With Emcure To Launch Weight Loss Drug Poviztra In India
- Tuesday November 11, 2025
- Health | Press Trust of India
Emcure Pharma becomes the first Indian company to hold exclusive rights to distribute and commercialise Poviztra, a semaglutide injection 2.4 mg for weight loss, the statement said.
-
www.ndtv.com
-
Why 'Bluetoothing', A Shocking Blood-Sharing Trend To Get High, Has Health Experts Worried
- Thursday October 9, 2025
- Lifestyle | Written by NDTV Lifestyle Desk
Bluetoothing is a practice where one person injects themselves with a drug, then another person injects that first users blood into their own body
-
www.ndtv.com/lifestyle
-
Ozempic Launched In India: 14 Facts About The Diabetes, Weight Loss Drug
- Friday December 12, 2025
- Health | Written by Shreya Goswami
Semaglutide (Ozempic), a once-weekly injectable already approved globally, has now been launched in India for type 2 diabetes.
-
www.ndtv.com
-
Ozempic Cleared For Use In India: Pros, Cons And Prices
- Friday December 12, 2025
- Health | Reported by Tanushka Dutta
Ozempic is the trade name for semaglutide, a once-weekly injectable medicine that belongs to the class called GLP-1 receptor agonists. A higher-dose semaglutide better known as Wegovy is licensed for chronic weight management.
-
www.ndtv.com